Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM

Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM
Cathie Wood’s Ark Invest leaned into volatility on Wednesday, buying shares of Tempus AI after a post-earnings pullback while trimming exposure to Pinterest following recent weakness in its outlook. Tempus AI shares fell more than 7% to $53.71 after the company reported a https://t.co/0IaJbvpWYn
Nancy Pelosi’s investment in Tempus AI is turning heads after the stock surged more than 200% this year. Earlier in 2025, Pelosi disclosed the purchase of 50 call options in Tempus AI, a healthcare-focused artificial intelligence company. The options, which expire in 2026 with a https://t.co/RQcfR1BVPT
Cathie Wood’s Ark Invest made a series of high-profile moves on Tuesday, reshuffling its portfolio across several sectors. The firm increased exposure to Advanced Micro Devices, Bullish, and Figma, while trimming its stake in Tempus AI. Ark’s Fintech Innovation ETF added nearly https://t.co/QvBQeiAvDv
Cathie Wood’s Ark Invest made several high-profile trades this week, shifting away from Tempus AI while increasing positions in Amazon, Figma, and crypto-focused Bullish. Ark sold more than 58,000 shares of Tempus AI across its ARK Genomic Revolution and ARK Innovation funds. https://t.co/DTZ8k1O1wA
Tempus AI announces $81.25M acquisition of Paige
7.48BUSD

Scopri quali miliardari possiedono questo investimento
Tipo
Common Stock
Borsa
NASDAQ
Codice valuta
USD
Nome valuta
US Dollar
Nome del paese
USA
ISO del paese
US
ISIN
US88023B1035
CUSIP
-
Settore
Healthcare
Settore
Health Information Services
Chiusura dell'anno fiscale
December
Data dell'IPO
-
Aggiornato il
-
Rapporto P/E
-
Rapporto PEG
-
Valore contabile
2.32
Dividendi per azione
-
Rendimento dei dividendi
-
Guadagni per azione
-1.83
Prezzo obiettivo di Wall Street
67.23
Stima EPS anno corrente
-0.36
Stima EPS anno successivo
-0.08
Stima EPS trimestre corrente
-0.2011
Stima EPS trimestre successivo
-0.1483
Trimestre più recente
-
Ricavi TTM
1,364,167,936
Margine di profitto lordo TTM
864,734,976
EBITDA
-185,246,000
Margine di profitto
-22.21%
Rendimento sugli attivi TTM
-9.07%
Rendimento sul patrimonio TTM
-81.58%
Ricavi per azione TTM
7.735
Crescita dei ricavi trimestrali su base annua
36.10%
EPS diluiti TTM
-1.83
Crescita degli utili trimestrali su base annua
0.00%
Rapporto P/E trascinato
0.00
Rapporto P/E previsto
0
Rapporto prezzo/vendite TTM
5.846
Rapporto prezzo/libro MRQ
17.9669
Valore aziendale sui ricavi
5
Valore aziendale su EBITDA
0
203.19
0.55%21.11
0.26%0.97
0.00%112.23
0.00%59.68
-18.13%5.52
-6.76%46.54
-5.87%74.71
-0.65%49.87
-0.53%100.62
-0.39%